New Strong Sell Stocks for September 9th

Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:


Assertio Holdings, Inc.


ASRT

is a commercial pharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.


Calavo Growers, Inc.


CVGW

markets and distributes avocados, prepared avocados, and other perishable foods. The Zacks Consensus Estimate for its current year earnings has been revised 67.5% downward over the last 30 days.


Nutriband Inc.


NTRB

develops a portfolio of transdermal pharmaceutical products. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.


Integra Resources Corp.


ITRG

is a mineral resources company. The Zacks Consensus Estimate for its current year earnings has been revised 2.8% downward over the last 30 days.


Kirin Holdings Company, Limited


KNBWY

produces and sells alcoholic beverages, soft drinks, pharmaceuticals, and other related products. The Zacks Consensus Estimate for its current year earnings has been revised 18.8% downward over the last 30 days.

View the entire

Zacks Rank #5 List.


Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.


See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report


To read this article on Zacks.com click here.


Zacks Investment Research